A multifunctional approach: merging CRISPR/Cas technology with DNA nanomachines for advanced biosensing
Analytical and Bioanalytical Chemistry · 2026
DOI: 10.1007/s00216-025-06182-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Analytical and Bioanalytical Chemistry, 2026. Verfasst von Aijiao Yuan und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beiji…. Hauptthemen laut MEDLINE: Biosensing Techniques, CRISPR-Cas Systems, DNA, Nanostructures. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 108 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Strategic Priority Research Program of the Chinese Academy of Sciences.
Abstract (Originalsprache)
CRISPR/Cas systems have revolutionized nucleic acid recognition, offering unparalleled programmability for biosensing. Simultaneously, DNA nanomachines have emerged as powerful bioanalytical tools due to their structural precision, biocompatibility, and multifunctional capabilities. The strategic integration of these platforms synergistically enhances sensitivity, specificity, and multiplexing potential, creating next-generation bioanalytical systems. While promising, this convergence presents unique engineering challenges and necessitates critical evaluation. This review systematically analyzes the target recognition mechanisms of CRISPR/Cas systems and critically evaluates prevalent signal readout modalities. A core focus is the critical assessment of innovative biosensing strategies that leverage DNA nanomachines-particularly dynamic walker systems-coupled with CRISPR/Cas activation. We highlight representative integrated platforms, detailing their operational principles and objectively examining their demonstrated advantages against inherent limitations such as signal leakage, complex assembly, and in vivo applicability constraints. By providing a critical analysis of the synergistic potential and current constraints of CRISPR/Cas-DNA nanomachine integration, this review aims to guide rational design towards robust, clinically translatable precision diagnostics and therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, 100085, China.
- University of Chinese Academy of Sciences, Beijing, 100049, China.
- State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, 100085, China. hypeng@rcees.ac.cn.
- University of Chinese Academy of Sciences, Beijing, 100049, China. hypeng@rcees.ac.cn.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Strategic Priority Research Program of the Chinese Academy of Sciences
Zitieren
APA
Yuan, A., Sun, T., Deng, Z., Ye, L., Shang, Y., Xie, W., & Peng, H. (2026). A multifunctional approach: merging CRISPR/Cas technology with DNA nanomachines for advanced biosensing. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-025-06182-7
Vancouver
Yuan A, Sun T, Deng Z, Ye L, Shang Y, Xie W, et al. A multifunctional approach: merging CRISPR/Cas technology with DNA nanomachines for advanced biosensing. Analytical and Bioanalytical Chemistry. 2026. doi:10.1007/s00216-025-06182-7
BibTeX
@article{Yuan2026,
author = {Yuan, Aijiao and Sun, Tianrui and Deng, Zhaojia and Ye, Lei and Shang, Yingxu and Xie, Wenjing and Peng, Hanyong},
title = {A multifunctional approach: merging CRISPR/Cas technology with DNA nanomachines for advanced biosensing},
journal = {Analytical and Bioanalytical Chemistry},
year = {2026},
doi = {10.1007/s00216-025-06182-7}
}
EUVIMED